Level Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28
| Closed | -$1.75K | – | 115 |
|
|
2023
Q4 | $1.75K | Buy |
+28
| New | +$1.75K | ﹤0.01% | 246 |
|
|
2023
Q3 | – | Sell |
-47
| Closed | -$2.64K | – | 290 |
|
|
2023
Q2 | $2.64K | Hold |
47
| – | – | ﹤0.01% | 242 |
|
|
2023
Q1 | $2.13K | Hold |
47
| – | – | ﹤0.01% | 210 |
|
|
2022
Q4 | $2K | Hold |
47
| – | – | ﹤0.01% | 217 |
|
|
2022
Q3 | $3K | Hold |
47
| – | – | ﹤0.01% | 208 |
|
|
2022
Q2 | $3K | Hold |
47
| – | – | ﹤0.01% | 232 |
|
|
2022
Q1 | $3K | Buy |
+47
| New | +$3K | ﹤0.01% | 195 |
|